Along these anti-tumor properties, interestingly, manzamine A administration led to a significant decrease in SIX1 and CK2α proteins intracellular level along with the regulation of cell-cycle related checkpoint proteins in the mentioned cell lines, suggesting possible activity in vivo against cervical cancer, since it expresses high levels of SIX1. This evidence concerns the gene SIX1 and cervical carcinoma.